RT Journal Article
SR Electronic
T1 EVALUATION OF FUNCTIONAL OUTCOME MEASURES AS A SURROGATE MARKER OF DISEASE SEVERITY IN PATIENTS WITH MITOCHONDRIAL DISEASE
JF Journal of Neurology, Neurosurgery & Psychiatry
JO J Neurol Neurosurg Psychiatry
FD BMJ Publishing Group Ltd
SP e2
OP e2
DO 10.1136/jnnp-2013-306573.199
VO 84
IS 11
A1 Jane Newman
A1 Brook Galna
A1 Djordje Jakovljevic
A1 Matthew Bates
A1 Andrew Schaefer
A1 Robert McFarland
A1 Douglass Turnbull
A1 Michael Trenell
A1 Lynn Rochester
A1 Grainne Gorman
YR 2013
UL http://jnnp.bmj.com/content/84/11/e2.111.abstract
AB Objectives Mitochondrial diseases are a heterogeneous group of genetic disorders, resulting in significant morbidity and disability. The molecular basis of many of the common mitochondrial disorders has been elucidated over the last decade; yet currently there are no known cures and few effective treatments. This is compounded by the paucity of natural history studies and the lack of uniformity and relevance of outcome measures in therapeutic trials, research and clinical settings, in this patient population. Functional outcome measures have proven reliable measures to monitor natural history and interventions in other neurological conditions. We sought to evaluate the usefulness of validated functional outcome measures for patients with mitochondrial disease. Methods Twenty–four patients and 12 sedentary controls were recruited to this case control observational study. This included the six minute timed walk (6MTW), 10 meter walk test (10MWT), Timed up and Go (TUG) and the 5 times sit to stand (5XSTS). These functional measures were compared to clinical measures of peak exercise capacity, proximal muscle strength and disease burden. Results All clinical measures used detected significant differences between patients and sedentary controls. Disease severity correlated with TUG (r=0.63, p=.02) and 10MTW (r=0.62, p=.001). Receiver Operating Curve analysis revealed 5XSTS to be the most responsive measure. Conclusion The 10 MTW, 6 MTW, TUG and 5 XSTS are valid evaluative outcome measures in patients with mitochondrial disease. The 5XSTS can be used to discriminate between mitochondrial and sedentary controls with high accuracy and 10 MTW and TUG may serve as useful surrogate markers of disease severity.